Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,3/35,0.0007067159044822667,0.0975267948185528,0,0,19.202319587628867,139.31055899468168,QPRT;NADSYN1;SIRT2
KEGG_2021_Human,Salmonella infection,6/249,0.0015760728535172,0.1087490268926887,0,0,5.163383241397426,33.3183778032813,TRADD;VPS33A;CTNNB1;GCC2;EXOC2;PIK3CG
KEGG_2021_Human,Adherens junction,3/71,0.0054200564280536,0.2493225956904661,0,0,9.020012128562763,47.06325773617709,CTNNB1;NECTIN4;NECTIN1
KEGG_2021_Human,mRNA surveillance pathway,3/98,0.0130939766052085,0.3696500383355797,0,0,6.447639717851329,27.954405817650997,PABPC3;CASC3;SMG5
KEGG_2021_Human,RNA transport,4/186,0.0142159977931596,0.3696500383355797,0,0,4.51419413919414,19.200616217146138,EIF2B5;NUP42;PABPC3;CASC3
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,4/193,0.0160717407971991,0.3696500383355797,0,0,4.345458553791887,17.949754270462787,TRADD;CTNNB1;CALML3;PIK3CG
KEGG_2021_Human,Fluid shear stress and atherosclerosis,3/139,0.0325947616635109,0.602988315523649,0,0,4.4945421467556095,15.387531072601112,MGST3;CTNNB1;CALML3
KEGG_2021_Human,RNA degradation,2/79,0.0594897545967717,0.602988315523649,0,0,5.253909355950173,14.8262756693766,EXOSC6;PABPC3
KEGG_2021_Human,Th1 and Th2 cell differentiation,2/92,0.0775653030615549,0.602988315523649,0,0,4.492063492063492,11.484567093173029,NOTCH1;CD3G
KEGG_2021_Human,Human papillomavirus infection,4/331,0.0844574160858518,0.602988315523649,0,0,2.4940112130479104,6.163968224425985,NOTCH1;TRADD;CTNNB1;LLGL1
KEGG_2021_Human,Pathways of neurodegeneration,5/475,0.0898344701970152,0.602988315523649,0,0,2.175811870100784,5.243242119252655,ATG101;SEPTIN5;CTNNB1;CALML3;MAPT
KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.0902192838327616,0.602988315523649,0,0,2.9138755980861246,7.009362965508448,TRADD;CALML3;CD3G
KEGG_2021_Human,Melanogenesis,2/101,0.0909569913965944,0.602988315523649,0,0,4.081838796124511,9.785671777221246,CTNNB1;CALML3
KEGG_2021_Human,Human cytomegalovirus infection,3/225,0.1031902700601577,0.602988315523649,0,0,2.741432153803288,6.226287833009744,TRADD;CTNNB1;CALML3
KEGG_2021_Human,Mismatch repair,1/23,0.1089472978360328,0.602988315523649,0,0,9.1267217630854,20.232947516534363,LIG1
KEGG_2021_Human,Protein export,1/23,0.1089472978360328,0.602988315523649,0,0,9.1267217630854,20.232947516534363,SEC63
KEGG_2021_Human,Thermogenesis,3/232,0.1104659121595449,0.602988315523649,0,0,2.656687525323009,5.852810917325962,KDM3A;COA1;ATP5ME
KEGG_2021_Human,Alzheimer disease,4/369,0.1137690179944684,0.602988315523649,0,0,2.230022831050228,4.847144273273048,ATG101;CTNNB1;CALML3;MAPT
KEGG_2021_Human,Folate biosynthesis,1/26,0.1222622476286691,0.602988315523649,0,0,8.030303030303031,16.876380218002918,PCBD1
KEGG_2021_Human,Thyroid hormone signaling pathway,2/121,0.1228182019197929,0.602988315523649,0,0,3.392385525638827,7.1140022366712525,NOTCH1;CTNNB1
KEGG_2021_Human,Parkinson disease,3/249,0.128921631654778,0.602988315523649,0,0,2.470958008549158,5.061882426430637,SEPTIN5;CALML3;MAPT
KEGG_2021_Human,Phototransduction,1/28,0.1310292553948657,0.602988315523649,0,0,7.434717545828657,15.109834134055738,CALML3
KEGG_2021_Human,Galactose metabolism,1/31,0.1440174715013112,0.602988315523649,0,0,6.69023569023569,12.964476920040203,GAA
KEGG_2021_Human,RNA polymerase,1/31,0.1440174715013112,0.602988315523649,0,0,6.69023569023569,12.964476920040203,POLR1D
KEGG_2021_Human,Apelin signaling pathway,2/137,0.1499507080843318,0.602988315523649,0,0,2.9879062736205597,5.669398730173793,CALML3;PIK3CG
KEGG_2021_Human,Autophagy,2/137,0.1499507080843318,0.602988315523649,0,0,2.9879062736205597,5.669398730173793,ATG101;RAB33B
KEGG_2021_Human,Base excision repair,1/33,0.152569319997184,0.602988315523649,0,0,6.271464646464646,11.79120788980768,LIG1
KEGG_2021_Human,Fructose and mannose metabolism,1/33,0.152569319997184,0.602988315523649,0,0,6.271464646464646,11.79120788980768,GFUS
KEGG_2021_Human,Measles,2/139,0.1534237633251,0.602988315523649,0,0,2.9439892745419334,5.518659484645247,TRADD;CD3G
KEGG_2021_Human,Starch and sucrose metabolism,1/36,0.165238740567014,0.602988315523649,0,0,5.733044733044733,10.321566994169176,GAA
KEGG_2021_Human,DNA replication,1/36,0.165238740567014,0.602988315523649,0,0,5.733044733044733,10.321566994169176,LIG1
KEGG_2021_Human,Breast cancer,2/147,0.1674678305136682,0.602988315523649,0,0,2.780436312456017,4.968539602428729,NOTCH1;CTNNB1
KEGG_2021_Human,Cell adhesion molecules,2/148,0.1692391088589375,0.602988315523649,0,0,2.761252446183953,4.905206802489739,CD226;NECTIN1
KEGG_2021_Human,Thyroid cancer,1/37,0.1694200671801256,0.602988315523649,0,0,5.57351290684624,9.895070145641316,CTNNB1
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,2/150,0.1727913280938574,0.602988315523649,0,0,2.7236624379481524,4.7818540898178,CALML3;PIK3CG
KEGG_2021_Human,Primary immunodeficiency,1/38,0.1735806579316256,0.602988315523649,0,0,5.422604422604422,9.495592558231127,IGLL1
KEGG_2021_Human,Oxytocin signaling pathway,2/154,0.1799323214637967,0.602988315523649,0,0,2.651450053705693,4.547699495381422,CALML3;PIK3CG
KEGG_2021_Human,Hepatitis C,2/157,0.1853177460113514,0.602988315523649,0,0,2.599736668861093,4.382332898174394,TRADD;CTNNB1
KEGG_2021_Human,Ferroptosis,1/41,0.1859390303366049,0.602988315523649,0,0,5.015151515151516,8.43717221072756,FTH1
KEGG_2021_Human,Ribosome,2/158,0.1871181588639223,0.602988315523649,0,0,2.5829408686551543,4.329047629874819,MRPS17;MRPL24
KEGG_2021_Human,Necroptosis,2/159,0.188921090423562,0.602988315523649,0,0,2.566359027687508,4.276647055148966,FTH1;TRADD
KEGG_2021_Human,Hippo signaling pathway,2/163,0.1961566278092089,0.602988315523649,0,0,2.502091519837749,4.075511298482724,CTNNB1;LLGL1
KEGG_2021_Human,ABC transporters,1/45,0.2021326772791743,0.602988315523649,0,0,4.558310376492194,7.287967841732019,ABCB10
KEGG_2021_Human,cGMP-PKG signaling pathway,2/167,0.2034270342994011,0.602988315523649,0,0,2.440940012368584,3.887069777699034,CALML3;PIK3CG
KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.2052495909264702,0.602988315523649,0,0,2.426112613720187,3.841818525538327,MGST3;CTNNB1
KEGG_2021_Human,Nucleotide excision repair,1/47,0.2101094941683413,0.602988315523649,0,0,4.359683794466403,6.801658146757973,LIG1
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.2140682440880332,0.602988315523649,0,0,4.266709649688373,6.576964036635908,GFUS
KEGG_2021_Human,Tuberculosis,2/180,0.2272471444291937,0.602988315523649,0,0,2.2611786287548727,3.350427066998389,TRADD;CALML3
KEGG_2021_Human,Fanconi anemia pathway,1/54,0.2374116024468537,0.602988315523649,0,0,3.7825424051839143,5.43914439332398,UBE2T
KEGG_2021_Human,Alcoholism,2/186,0.2383134061741662,0.602988315523649,0,0,2.186779059449867,3.136209947287738,CALML3;HDAC6
KEGG_2021_Human,Glutathione metabolism,1/57,0.2488245414130006,0.602988315523649,0,0,3.5793650793650795,4.978922896997587,MGST3
KEGG_2021_Human,Endometrial cancer,1/58,0.2525911479606718,0.602988315523649,0,0,3.5163919900762006,4.8384959983786695,CTNNB1
KEGG_2021_Human,Notch signaling pathway,1/59,0.256339055642632,0.602988315523649,0,0,3.4555903866248694,4.703937185372145,NOTCH1
KEGG_2021_Human,Mineral absorption,1/60,0.2600683562676618,0.602988315523649,0,0,3.396849854476973,4.574913980988086,FTH1
KEGG_2021_Human,Epstein-Barr virus infection,2/202,0.2679339282131197,0.602988315523649,0,0,2.010204081632653,2.647468657967029,TRADD;CD3G
KEGG_2021_Human,Viral carcinogenesis,2/203,0.2697872573969225,0.602988315523649,0,0,2.000101533150574,2.620376153040449,TRADD;HDAC6
KEGG_2021_Human,Basal cell carcinoma,1/63,0.2711455282609312,0.602988315523649,0,0,3.231997393287716,4.218078497375417,CTNNB1
KEGG_2021_Human,Cytosolic DNA-sensing pathway,1/63,0.2711455282609312,0.602988315523649,0,0,3.231997393287716,4.218078497375417,POLR1D
KEGG_2021_Human,Pathways in cancer,4/531,0.2747651653080029,0.602988315523649,0,0,1.531704617330803,1.9787149806959017,NOTCH1;MGST3;CTNNB1;CALML3
KEGG_2021_Human,Rap1 signaling pathway,2/210,0.2827567896449933,0.602988315523649,0,0,1.9321036106750396,2.440571746176788,CTNNB1;CALML3
KEGG_2021_Human,Long-term potentiation,1/67,0.2856600898087258,0.602988315523649,0,0,3.0355065809611266,3.8033460819667058,CALML3
KEGG_2021_Human,Adipocytokine signaling pathway,1/69,0.2928096888806698,0.602988315523649,0,0,2.9459298871063577,3.6182865561027495,TRADD
KEGG_2021_Human,Amphetamine addiction,1/69,0.2928096888806698,0.602988315523649,0,0,2.9459298871063577,3.6182865561027495,CALML3
KEGG_2021_Human,Renin secretion,1/69,0.2928096888806698,0.602988315523649,0,0,2.9459298871063577,3.6182865561027495,CALML3
KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.2963578762035246,0.602988315523649,0,0,2.9030888596105986,3.530700422312052,TRADD
KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.3068970331118836,0.602988315523649,0,0,2.781705948372615,3.2858706369655613,PIK3CG
KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.3138361616484454,0.602988315523649,0,0,2.7062517062517064,3.1362323637249645,TTF1
KEGG_2021_Human,Glioma,1/75,0.3138361616484454,0.602988315523649,0,0,2.7062517062517064,3.1362323637249645,CALML3
KEGG_2021_Human,Gastric acid secretion,1/76,0.3172798893506643,0.602988315523649,0,0,2.67003367003367,3.065121123308704,CALML3
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,1/76,0.3172798893506643,0.602988315523649,0,0,2.67003367003367,3.065121123308704,MGST3
KEGG_2021_Human,Pertussis,1/76,0.3172798893506643,0.602988315523649,0,0,2.67003367003367,3.065121123308704,CALML3
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.3207065055587057,0.602988315523649,0,0,2.6347687400318978,2.996335121708695,CTNNB1
KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.3207065055587057,0.602988315523649,0,0,2.6347687400318978,2.996335121708695,CTNNB1
KEGG_2021_Human,Ras signaling pathway,2/232,0.3233415604981886,0.602988315523649,0,0,1.7453416149068324,1.9705710590679104,CALML3;EXOC2
KEGG_2021_Human,Chemical carcinogenesis,2/239,0.3361522419748238,0.6080343644954859,0,0,1.693188667872212,1.8458992510839436,SULT1A1;MGST3
KEGG_2021_Human,Colorectal cancer,1/86,0.3507897886854045,0.6080343644954859,0,0,2.354723707664884,2.46673350535558,CTNNB1
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.3605214364245345,0.6080343644954859,0,0,2.2741046831955924,2.32005037808893,CD3G
KEGG_2021_Human,Salivary secretion,1/93,0.3732726494349856,0.6080343644954859,0,0,2.1747913921826965,2.143139832163484,CALML3
KEGG_2021_Human,GnRH signaling pathway,1/93,0.3732726494349856,0.6080343644954859,0,0,2.1747913921826965,2.143139832163484,CALML3
KEGG_2021_Human,IL-17 signaling pathway,1/94,0.3764209201158763,0.6080343644954859,0,0,2.1512979254914737,2.101919815261755,TRADD
KEGG_2021_Human,Circadian entrainment,1/97,0.3857720948428521,0.6080343644954859,0,0,2.083754208754209,1.9847936202473104,CALML3
KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.3857720948428521,0.6080343644954859,0,0,2.083754208754209,1.9847936202473104,CALML3
KEGG_2021_Human,Prostate cancer,1/97,0.3857720948428521,0.6080343644954859,0,0,2.083754208754209,1.9847936202473104,CTNNB1
KEGG_2021_Human,Aldosterone synthesis and secretion,1/98,0.3888581963975129,0.6080343644954859,0,0,2.062168072477351,1.947801335478516,CALML3
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,1/98,0.3888581963975129,0.6080343644954859,0,0,2.062168072477351,1.947801335478516,CALML3
KEGG_2021_Human,Hematopoietic cell lineage,1/99,0.3919289465238684,0.6080343644954859,0,0,2.0410224695938983,1.9117741389719491,CD3G
KEGG_2021_Human,Chagas disease,1/102,0.4010498423953424,0.6080343644954859,0,0,1.98009800980098,1.8091552855878603,CD3G
KEGG_2021_Human,Longevity regulating pathway,1/102,0.4010498423953424,0.6080343644954859,0,0,1.98009800980098,1.8091552855878603,ATG101
KEGG_2021_Human,T cell receptor signaling pathway,1/104,0.4070550586365517,0.6080343644954859,0,0,1.9414533686378344,1.7449915352070269,CD3G
KEGG_2021_Human,C-type lectin receptor signaling pathway,1/104,0.4070550586365517,0.6080343644954859,0,0,1.9414533686378344,1.7449915352070269,CALML3
KEGG_2021_Human,NF-kappa B signaling pathway,1/104,0.4070550586365517,0.6080343644954859,0,0,1.9414533686378344,1.7449915352070269,TRADD
KEGG_2021_Human,Th17 cell differentiation,1/107,0.4159512905205901,0.6080343644954859,0,0,1.886220697541452,1.654568493195685,CD3G
KEGG_2021_Human,Glucagon signaling pathway,1/107,0.4159512905205901,0.6080343644954859,0,0,1.886220697541452,1.654568493195685,CALML3
KEGG_2021_Human,Drug metabolism,1/108,0.4188872357630098,0.6080343644954859,0,0,1.8684980647597471,1.6258801725332537,MGST3
KEGG_2021_Human,TNF signaling pathway,1/112,0.4304856163806702,0.6080343644954859,0,0,1.8008008008008007,1.517789408820894,TRADD
KEGG_2021_Human,Toxoplasmosis,1/112,0.4304856163806702,0.6080343644954859,0,0,1.8008008008008007,1.517789408820894,PIK3CG
KEGG_2021_Human,Cholinergic synapse,1/113,0.4333492188372186,0.6080343644954859,0,0,1.7846320346320346,1.492329591518098,PIK3CG
KEGG_2021_Human,MAPK signaling pathway,2/294,0.4336474073221412,0.6080343644954859,0,0,1.3704221414593234,1.145019904936257,TRADD;MAPT
KEGG_2021_Human,Leukocyte transendothelial migration,1/114,0.4361985658337181,0.6080343644954859,0,0,1.768749441315813,1.4674566165007243,CTNNB1
KEGG_2021_Human,Sphingolipid signaling pathway,1/119,0.450233917137087,0.6151710947021586,0,0,1.6933744221879816,1.3512924945163796,TRADD
KEGG_2021_Human,Neurotrophin signaling pathway,1/119,0.450233917137087,0.6151710947021586,0,0,1.6933744221879816,1.3512924945163796,CALML3
KEGG_2021_Human,Herpes simplex virus 1 infection,3/498,0.4555071383333122,0.6162743636274225,0,0,1.2124336144954702,0.9533897659792792,EIF2B5;TRADD;NECTIN1
KEGG_2021_Human,Platelet activation,1/124,0.4639232772068564,0.6215671092674387,0,0,1.6241274533957462,1.2473885010387038,PIK3CG
KEGG_2021_Human,Lysosome,1/128,0.4746313336381609,0.6231965688415223,0,0,1.572655690765927,1.171969623816576,GAA
KEGG_2021_Human,Oocyte meiosis,1/129,0.4772750912018035,0.6231965688415223,0,0,1.560290404040404,1.1540879003160078,CALML3
KEGG_2021_Human,Dopaminergic synapse,1/132,0.4851275940329752,0.6231965688415223,0,0,1.5243272418844938,1.1026119616962,CALML3
KEGG_2021_Human,Vascular smooth muscle contraction,1/133,0.487719053875974,0.6231965688415223,0,0,1.512702785430058,1.0861444222602046,CALML3
KEGG_2021_Human,Oxidative phosphorylation,1/133,0.487719053875974,0.6231965688415223,0,0,1.512702785430058,1.0861444222602046,ATP5ME
KEGG_2021_Human,Estrogen signaling pathway,1/137,0.4979563925252978,0.6247089288044646,0,0,1.467914438502674,1.0234927306951356,CALML3
KEGG_2021_Human,Insulin signaling pathway,1/137,0.4979563925252978,0.6247089288044646,0,0,1.467914438502674,1.0234927306951356,CALML3
KEGG_2021_Human,Apoptosis,1/142,0.5104686592356167,0.6264147445800191,0,0,1.4155025431621175,0.9518207634132154,TRADD
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.5129338125908852,0.6264147445800191,0,0,1.4054630815194196,0.9382990468495096,CTNNB1
KEGG_2021_Human,Spinocerebellar ataxia,1/143,0.5129338125908852,0.6264147445800191,0,0,1.4054630815194196,0.9382990468495096,ATG101
KEGG_2021_Human,Phospholipase D signaling pathway,1/148,0.5250764322021929,0.6329624965803381,0,0,1.357314643028929,0.874397623216168,PIK3CG
KEGG_2021_Human,Gastric cancer,1/149,0.5274687471502818,0.6329624965803381,0,0,1.348075348075348,0.8623175106205572,CTNNB1
KEGG_2021_Human,Cushing syndrome,1/155,0.5415741406288901,0.6384323910364588,0,0,1.295159386068477,0.7942892672270463,CTNNB1
KEGG_2021_Human,Cellular senescence,1/156,0.5438841666005395,0.6384323910364588,0,0,1.2867383512544803,0.7836480831514409,CALML3
KEGG_2021_Human,Amyotrophic lateral sclerosis,2/364,0.545905957552914,0.6384323910364588,0,0,1.101477054910362,0.6667334866611279,ATG101;HDAC6
KEGG_2021_Human,Wnt signaling pathway,1/166,0.566359876814798,0.6552910713096197,0,0,1.2081420263238445,0.6868596439049133,CTNNB1
KEGG_2021_Human,Tight junction,1/169,0.5728862133976284,0.6552910713096197,0,0,1.1863876863876863,0.6608988084033616,LLGL1
KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.5771829849119133,0.6552910713096197,0,0,1.172311348781937,0.6442975473743275,SEC63
KEGG_2021_Human,Influenza A,1/172,0.5793152949258957,0.6552910713096197,0,0,1.1653966566247267,0.6361998227862873,TRADD
KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.6139778143964273,0.6888531576155038,0,0,1.0591016548463357,0.5166260638484753,HDAC6
KEGG_2021_Human,Chemokine signaling pathway,1/192,0.6197942035221659,0.6897709684359588,0,0,1.042307895711037,0.4986065202419767,PIK3CG
KEGG_2021_Human,Pathogenic Escherichia coli infection,1/197,0.6292959845517696,0.6947427669451537,0,0,1.015460729746444,0.4703142614525967,TRADD
KEGG_2021_Human,Focal adhesion,1/201,0.6367278257975183,0.6973685711115677,0,0,0.9949494949494948,0.4491331261764552,CTNNB1
KEGG_2021_Human,Proteoglycans in cancer,1/205,0.6440121337651465,0.699792712280238,0,0,0.975242622301446,0.4291435319722849,CTNNB1
KEGG_2021_Human,Lipid and atherosclerosis,1/215,0.6615963365459056,0.7095182380258632,0,0,0.9291985273293684,0.3838516073758758,CALML3
KEGG_2021_Human,cAMP signaling pathway,1/216,0.6633067349218524,0.7095182380258632,0,0,0.9248296922715528,0.3796590033348701,CALML3
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,1/219,0.6683867459663929,0.7095182380258632,0,0,0.9119636734315634,0.3674195049496875,CD3G
KEGG_2021_Human,Calcium signaling pathway,1/240,0.7018835601138744,0.7393887885169058,0,0,0.8309454376399983,0.2941445120731517,CALML3
KEGG_2021_Human,Shigellosis,1/246,0.7108229973595908,0.7431331336032085,0,0,0.8103483817769532,0.276597695305975,TRADD
KEGG_2021_Human,Endocytosis,1/252,0.7194969722870609,0.7465457306437173,0,0,0.7907360457161254,0.2603126474157279,SPG21
KEGG_2021_Human,Prion disease,1/273,0.7478760316439829,0.7702006893049973,0,0,0.7289067142008319,0.2117605556665016,NOTCH1
KEGG_2021_Human,Huntington disease,1/306,0.7868328435807778,0.8027641205078749,0,0,0.6489485014075178,0.1555785568700312,ATG101
KEGG_2021_Human,MicroRNAs in cancer,1/310,0.7911298578918188,0.8027641205078749,0,0,0.6404171161452715,0.150045346926481,NOTCH1
KEGG_2021_Human,PI3K-Akt signaling pathway,1/354,0.8330931306732685,0.8391741024300078,0,0,0.5593327038086245,0.1021396564084433,PIK3CG
KEGG_2021_Human,Olfactory transduction,1/440,0.8924859861784817,0.8924859861784817,0,0,0.4477807689652792,0.0509325849939241,CALML3
